1,460
Views
20
CrossRef citations to date
0
Altmetric
Review

Systemic lupus erythematosus (SLE): emerging therapeutic targets

& ORCID Icon
Pages 1283-1302 | Received 24 Jun 2020, Accepted 01 Oct 2020, Published online: 01 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mengmeng Xiang, Yilun Wang, Qian Chen, Jie Wang, Zhanyan Gao, Jun Liang & Jinhua Xu. (2023) LncRNA NEAT1 promotes IL-6 secretion in monocyte-derived dendritic cells via sponging miR-365a-3p in systemic lupus erythematosus. Epigenetics 18:1.
Read now
Abdullah Ali Ahmed, Naureen Osman & Richard Furie. (2022) An evaluation of anifrolumab for use in adults with systemic lupus erythematosus. Expert Review of Clinical Immunology 18:11, pages 1095-1106.
Read now

Articles from other publishers (18)

Yaodong You, Kun Zhu, Jie Wang, Qi Liang, Wen Li, Lin Wang, Baojun Guo, Jing Zhou, Xuanlin Feng & Jianyou Shi. (2023) ROCK inhibitor: Focus on recent updates. Chinese Chemical Letters 34:12, pages 108336.
Crossref
Kazuko Fujita, Taku Kuwabara, Bing Wang, Kaoru Tanaka, Kei Ito, Yuri Akishima-Fukasawa, Tetuo Mikami, Yoshikiyo Akasaka & Toshiharu Ishii. (2023) Irradiation Attenuates Systemic Lupus Erythematosus-Like Morbidity in NZBWF1 Mice: Focusing on CD180-Negative Cells. Journal of Immunology Research 2023, pages 1-11.
Crossref
Huiting Chen, Jinxuan He, Linwei Wang, Yanbin Lin, Zhixiang Mou, Xiaoxuan Huang & Lan Chen. (2023) Identification of monocyte-associated biomarkers in systemic lupus erythematosus and their pan-cancer analysis. Lupus 32:12, pages 1369-1380.
Crossref
Hui-Yuan Li, Li-Feng Huang, Xiao-Rong Huang, Dan Wu, Xiao-Cui Chen, Ji-Xin Tang, Ning An, Hua-Feng Liu & Chen Yang. (2023) Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target. Journal of Immunology Research 2023, pages 1-12.
Crossref
Jing‐Wen Chen, Jing‐Yi Zhan, Si‐Ping Liang, Xiao‐Dan Wang, Chang‐Song Lin & Qiang Xu. (2023) A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report. International Journal of Rheumatic Diseases 26:7, pages 1417-1421.
Crossref
Rong-Bin Lu & Jian Huang. (2023) Testing relationship between tea intake and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study. Advances in Rheumatology 63:1.
Crossref
Rui Tian, Lin Yuan, Yuan Huang, Rui Zhang, Hao Lyu, Shuai Xiao, Dong Guo, Declan William Ali, Marek Michalak, Xing-Zhen Chen, Cefan Zhou & Jingfeng Tang. (2023) Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine. Frontiers in Pharmacology 13.
Crossref
Xingyun Zhao, Shifen Wang, Shengjun Wang, Jue Xie & Dawei Cui. (2022) mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus. Clinical Immunology 245, pages 109153.
Crossref
Juan Liu, Xiaomin Zhang & Xuetao Cao. (2022) Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications. Journal of Autoimmunity 132, pages 102856.
Crossref
De-Kai Xiong, Xiang Shi, Miao-Miao Han, Xing-Min Zhang, Na-Na Wu, Xiu-Yue Sheng & Ji-Nian Wang. (2022) The regulatory mechanism and potential application of IL-23 in autoimmune diseases. Frontiers in Pharmacology 13.
Crossref
Pedro Mendes‐Bastos, Ana Brasileiro, Pavel Kolkhir, Stefan Frischbutter, Jörg Scheffel, Sherezade Moñino‐Romero & Marcus Maurer. (2022) Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions. Allergy 77:8, pages 2355-2366.
Crossref
Xiao Luo, Sirong Piao, Haiqing Li, Yuxin Li, Wei Xia, Yifang Bao, Xueling Liu, Daoying Geng, Hao Wu & Liqin Yang. (2022) Multi-lesion radiomics model for discrimination of relapsing-remitting multiple sclerosis and neuropsychiatric systemic lupus erythematosus. European Radiology 32:8, pages 5700-5710.
Crossref
Jingqun Liu, Qing Ma, Qice Sun, Qihan Luo, Yiheng Wang, Cheng Wang, Akao Zhu, Lisha Zhao, Lu Yin, Jiang Lou, Yu Dong & Ping Qiu. (2022) Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice. Oxidative Medicine and Cellular Longevity 2022, pages 1-17.
Crossref
Fangru Chen, Jian Meng, Wenjie Yan, Mengjiao Wang, Yunfei Jiang & Jintao Gao. (2022) Identification of Novel Immune Cell-Relevant Therapeutic Targets and Validation of Roles of TK1 in BMSCs of Systemic Lupus Erythematosus. Frontiers in Molecular Biosciences 9.
Crossref
Sarah Tassinari, Silvia Moreno, Hartmut Komber, Riccardo Carloni, Michela Cangiotti, Maria Francesca Ottaviani & Dietmar Appelhans. (2022) Synthesis and biological and physico-chemical characterization of glycodendrimers and oligopeptides for the treatment of systemic lupus erythematosus. Nanoscale 14:12, pages 4654-4670.
Crossref
Ghulam Mustafa, Hafiza Salaha Mahrosh, Mahwish Salman, Sumaira Sharif, Raheela Jabeen, Tanveer Majeed & Hafsah Tahir. (2021) Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus. BioMed Research International 2021, pages 1-11.
Crossref
Helena Idborg & Vilija Oke. (2021) Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy. International Journal of Molecular Sciences 22:21, pages 11327.
Crossref
Yaqi Wang, Shengxiang Xiao, Yumin Xia & Huixia Wang. (2021) The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies. Clinical Reviews in Allergy & Immunology 63:2, pages 152-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.